Condition
Immunocompromised clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Immunocompromised clinical trials that are recruiting, at sites in 6 countries (most in United States (3), China (2), Israel (1)). By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 6Countries
Newest Immunocompromised clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Lyophilized Vero-cell Rabies Vaccine in Immunocompromised, Chronic Disease, and Elderly Patients | — | Shenzhen, Guangdong | Recruiting | Aug 13, 2025 |
| Alpha DaRT treatment for skin squamous cell cancer in immunocompromised patients | — | Gilbert, Arizona and 10 other locations | Recruiting | Sep 26, 2024 |
| DAS181 treatment for lower respiratory tract infections in immunocompromised patients | Phase 3 | Duarte, California and 27 other locations | Recruiting | Jan 18, 2019 |
| Using donor T cells to treat immunocompromised patients with adenovirus infections | Phase 1 | Houston, Texas | Recruiting | Feb 7, 2018 |
All recruiting trials (4)
-
Lyophilized Vero-cell Rabies Vaccine in Immunocompromised, Chronic Disease, and Elderly Patients
This project tests whether a freeze-dried Vero-cell rabies vaccine produces protective antibody responses and is safe in people exposed to rabies who are elderly, have chronic diseases, or are non-HIV immunocompromised.
-
Alpha DaRT treatment for skin squamous cell cancer in immunocompromised patients
This study tests whether placing Alpha DaRT seeds directly into a skin squamous cell carcinoma can shrink tumors and improve outcomes in people with compromised immune systems.
-
DAS181 treatment for lower respiratory tract infections in immunocompromised patients
This study is testing if a new treatment called DAS181 can help immunocompromised patients with lower respiratory infections caused by the parainfluenza virus and severe COVID-19 feel better.
-
Using donor T cells to treat immunocompromised patients with adenovirus infections
This study is testing whether using donated T cells can help immunocompromised patients fight off adenovirus infections.
Related topics
Quick answers
How many Immunocompromised clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), China (2 trials), Israel (1 trial), Australia (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.